Provided by Tiger Trade Technology Pte. Ltd.

MESOBLAST LTD

2.040
-0.030-1.45%
Volume:2.02M
Turnover:4.13M
Market Cap:2.65B
PE:-31.92
High:2.090
Open:2.070
Low:2.020
Close:2.070
52wk High:3.310
52wk Low:1.880
Shares:1.30B
Float Shares:786.49M
Volume Ratio:1.06
T/O Rate:0.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.064
EPS(LYR):-0.064
ROE:-9.86%
ROA:-4.11%
PB:3.23
PE(LYR):-31.92

Loading ...

Why Retail Investors Are Tracking These 3 Founder Led Australian Stocks Today

Simply Wall St.
·
Jul 24

Why Retail Investors Are Tracking These Founder Led Australian Stocks Today

Simply Wall St.
·
Jul 23

3 Australian Founder Led Stocks With Catalysts Investors May Be Missing

Simply Wall St.
·
Jul 22

Mesoblast Says CEO Makes Investment to Increase Share Ownership

Reuters
·
Jul 21

Mesoblast CEO Boosts Stake in Company With AU$2.7 Million Exercise of Options

MT Newswires Live
·
Jul 21

Stock Track | Mesoblast Plummets 5.14% Intraday on Profitability and Valuation Concerns Despite CEO Share Purchase

Stock Track
·
Jul 21

Mesoblast - CEO Exercises 1.9 Mln Options at A$1.45 Each for A$2.73 Mln

THOMSON REUTERS
·
Jul 21

Mesoblast - CEO Increases Shareholding to 80.8 Mln Shares

THOMSON REUTERS
·
Jul 21

Mesoblast Ltd-mesoblast CEO Makes Investment to Increase Share Ownership

THOMSON REUTERS
·
Jul 21

3 Founder Led Stocks With Real Management Alignment Investors May Want To Watch

Simply Wall St.
·
Jul 21

Flight Centre Stock And 2 Founder Led Australian Shares Backed By Long Term Focus

Simply Wall St.
·
Jul 20

Founder Led Australian Stocks With The Clearest Growth Story Right Now

Simply Wall St.
·
Jul 17

ASX Biggest Losers

MT Newswires Live
·
Jul 17

Founder Led Stocks For Investors Watching Australian Small Caps Closely

Simply Wall St.
·
Jul 16

Flight Centre Stock And 2 Founder Run ASX Shares Worth A Closer Look

Simply Wall St.
·
Jul 15

Mesoblast Achieves Patient Treatment Target in Phase 3 Trial of Chronic Lower Back Pain

MT Newswires Live
·
Jul 14

Mesoblast Achieves Target of 300 Treated Patients in Pivotal Phase 3 Trial for Chronic Low Back Pain

THOMSON REUTERS
·
Jul 14

ASX Stocks Estimated To Be Trading Below Fair Value In July 2026

Simply Wall St.
·
Jul 14

3 Australian Founder Led Stocks Backed By Strong Long Term Themes

Simply Wall St.
·
Jul 13

Stock Track | Mesoblast Soars 8.93% Intraday on Upbeat Ryoncil Cell Therapy Earnings

Stock Track
·
Jul 13